Lungpacer Announces New Category III CPT® Codes for AeroPace® Diaphragm Neurostimulation Therapy
New AMA Category III codes, effective July 1, 2026, support the development of future reimbursement pathways for temporary transvenous diaphragm neurostimulation EXTON, Pa., July 22, 2026 (GLOBE NEWSWIRE) — Lungpacer Medical today announced that new Category III Current Procedural Terminology (CPT®) codes granted by the American Medical Association (AMA) for temporary transvenous diaphragm neurostimulation with […]
\